Zengin N - Search Results

1

Efficacy of angiotensin-receptor blockers on demographic and clinico-pathological characteristics of breast cancer.

Sendur MA, Aksoy S, Yaman S, Ozdemir NY, Zengin N, Altundag K. Sendur MA, et al. Among authors: zengin n. Breast. 2012 Jun;21(3):419-20. doi: 10.1016/j.breast.2012.01.010. Epub 2012 Feb 11. Breast. 2012. PMID: 22326438 Free article. No abstract available.

2

Performance status scales may not correctly predict status of cancer patients with paraplegia.

Budakoglu B, Abali H, Oksüzoglu BC, Aksoy S, Zengin N. Budakoglu B, et al. Among authors: zengin n. Cancer Invest. 2006 Mar;24(2):221-2. doi: 10.1080/07357900500524777. Cancer Invest. 2006. PMID: 16537194 No abstract available.

3

It appears to be safe to start chemotherapy on the day of implantation through subcutaneous venous port catheters in inpatient setting.

Ozdemir NY, Abali H, Oksüzoğlu B, Budakoğlu B, Akmangit I, Zengin N. Ozdemir NY, et al. Among authors: zengin n. Support Care Cancer. 2009 Apr;17(4):399-403. doi: 10.1007/s00520-008-0498-x. Epub 2008 Sep 2. Support Care Cancer. 2009. PMID: 18762993

4

The efficacy and safety of reduced-dose docetaxel, cisplatin, and 5-fluorouracil in the first-line treatment of advanced stage gastric adenocarcinoma.

Ozdemir NY, Abali H, Oksüzoğlu B, Budakoglu B, Uncu D, Güler T, Odabaşi H, Zengin N. Ozdemir NY, et al. Among authors: zengin n. Med Oncol. 2010 Sep;27(3):680-4. doi: 10.1007/s12032-009-9268-y. Epub 2009 Jul 25. Med Oncol. 2010. PMID: 19633962

5

Adjuvant bi-weekly combination of cisplatin, infusional 5-fluorouracil and folinic acid followed by concomitant chemoradiotherapy with infusional fluorouracil for high risk operated gastric and gastroesophageal junction adenocarcinoma.

Uncu D, Ozdemir NY, Aksoy S, Abali H, Oksuzoglu BC, Budakoglu B, Yildiz R, Aslan N, Zengin N. Uncu D, et al. Among authors: zengin n. Asian Pac J Cancer Prev. 2010;11(6):1493-7. Asian Pac J Cancer Prev. 2010. PMID: 21338186 Free article.

6

Successful treatment of chronic hiccup with baclofen in cancer patients.

Seker MM, Aksoy S, Ozdemir NY, Uncu D, Civelek B, Akıncı MB, Zengin N. Seker MM, et al. Among authors: zengin n. Med Oncol. 2012 Jun;29(2):1369-70. doi: 10.1007/s12032-011-9910-3. Epub 2011 Mar 26. Med Oncol. 2012. PMID: 21442315

7

Frequency of HCV infection in renal cell carcinoma patients.

Budakoğlu B, Aksoy S, Arslan Ç, Üyetürk Ü, Babacan NA, Özcan MF, Yıldız R, Öven BB, Özdemir NY, Dizdar Ö, Büyükberber S, Akıncı MB, Türker I, Öksüzoğlu B, Altundag K, Zengin N. Budakoğlu B, et al. Among authors: zengin n. Med Oncol. 2012 Sep;29(3):1892-5. doi: 10.1007/s12032-011-9928-6. Epub 2011 Apr 3. Med Oncol. 2012. PMID: 21461964

8

Small cell carcinoma of the urinary bladder with hypercalcemia.

Sendur MA, Aksoy S, Arık Z, Yaman S, Ozdemir NY, Uncu D, Zengin N. Sendur MA, et al. Among authors: zengin n. Med Oncol. 2012 Jun;29(2):827-8. doi: 10.1007/s12032-011-9947-3. Med Oncol. 2012. PMID: 21499925 No abstract available.

9

Plasma VEGF levels may not accurately reflect the truth all the time.

Sendur MA, Aksoy S, Yaman S, Arık Z, Ozdemir NY, Zengin N. Sendur MA, et al. Among authors: zengin n. Med Oncol. 2012 Jun;29(2):1403-4. doi: 10.1007/s12032-011-9966-0. Med Oncol. 2012. PMID: 21533857 No abstract available.

10

Comparison of cisplatin-5-fluorouracil-folinic acid versus modified docetaxel-cisplatin-5-fluorouracil regimens in the first-line treatment of metastatic gastric cancer.

Kos FT, Uncu D, Ozdemir N, Budakoglu B, Odabaş H, Abali H, Oksuzoglu B, Aksoy S, Zengin N. Kos FT, et al. Among authors: zengin n. Chemotherapy. 2011;57(3):230-5. doi: 10.1159/000327840. Epub 2011 May 18. Chemotherapy. 2011. PMID: 21597287

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

257 results

Search Page